Nanobodies targeting the Epstein-Barr virus EBNA1 DNA binding domain inhibit tumor growth.

J Nanobiotechnology · 2026 · PMC13032330 · PMID 41724953

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

High-dose NbES9-TAT (5 mg/kg) significantly reduced EBER levels in tumor tissues, whereas the low-dose group (2 mg/kg) showed a downward trend that did not reach statistical significance (Fig. 6 E and S4H).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.